Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05581368

Studying the Effects of Cannabis on Vasculature

Cannabis is commonly used globally. It is associated with psychiatric problems, but the effects on the cardiovascular system are unclear. In this project, the investigators plan to study the effects of cannabis on the cardiovascular system. This will be done by using a non-invasive test to measure blood vessel function and by using blood samples to measure inflammation. As a control for this project, the investigators would like to test the blood vessel function and inflammation levels of participants who do not use cannabis. This study will provide important information on the long term cardiovascular effects of cannabis.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

London Regional Health Science Centre

London, Ontario, N6A 5A5, Canada

Location status: Recruiting

Location contact

Mark Chandy, MD, PhD

CONTACT

About this study

Cannabis is the most commonly used illicit drug in the world, but the investigators do not know the long-term effects on the cardiovascular system in humans. The investigators have data from cell culture and small animal studies that cannabis is toxic to the cardiovascular system. Recently legalized in Canada, the long-term effects of cannabis use on the cardiovascular system may not be apparent for several decades. The purpose of this study is to test the effect of cannabis use on the vascular system. Using a non-invasive test of vascular function, the investigators would like to assess the effects of cannabis on chronic cannabis users. The investigators would also like to test if cannabis use by smoking and/or vaping causes adverse cardiovascular effects acutely. Lastly, the investigators would like to test blood from chronic cannabis users for inflammatory cytokines, which could further support our hypothesis that cannabis damages the cardiovascular system via inflammation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age: 19 to 80
  • males and females
  • all ethnicities
  • cannabis use at least 3-4 times per week or more in the past 6 months (50 volunteers, experimental group)
  • patients who do not use cannabis (50 volunteers, control group)
  • no history of cardiovascular disease

Exclusion criteria

  • that ingest cannabis containing cannabidiol (CBD)
  • that are unable to provide a receipt for the cannabis product(s) they ingest
  • that are unwilling to stop consuming soy products and/or genistein 48 hours prior to appointments.

Treatment and study plan

Chronic Cannabis use

Other

The investigators will test levels of inflammation and vascular dysfunction in participants who chronically use cannabis.

Primary outcomes

  1. Inflammation

    Time frame: Baseline measurement.

    The investigators will measure the concentration of inflammatory cytokines using an Olink for chronic cannabis users and the control group.

  2. Endothelial function

    Time frame: Baseline measurement.

    The investigators will measure the reactive hyperaemia index (RHI) using an EndPAT device for both groups.

Secondary outcomes

  1. Cholesterol Level

    Time frame: Baseline measurement.

    The investigators will measure lipid profile (total cholesterol, LDL, HDL, ratio) for both groups.

  2. BMI

    Time frame: Baseline measurement.

    The investigators will measure body-mass index or both groups.

  3. Blood pressure

    Time frame: Baseline measurement.

    The investigators will measure baseline blood pressure for both groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Kerry-Ann Nakreiko, PhD

CONTACT

[email protected]

5196612111 ext. 80249

Mark Chandy, MD, PhD

CONTACT

[email protected]

5196612111

Sponsors and collaborators

Lead sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Other

Collaborators

  • Academic Medical Organization of Southwestern Ontario
  • Canadian Cardiovascular Society
  • Greenstone Biosciences
  • Stanford University

Registry information

Official study title

Elucidating the Effects of Cannabis on Cardiovascular System

Acronym: SECV

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Oct 14, 2022
Registry last updated
Jun 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.